Skip to content

Robert Hershberg, Director at Adaptive Biotechnologies, sold ADPT on Aug 18, 2026

Data as of Oct 16

▼ SELL$366K15,000 shares at $24.39Robert Hershberg DirectorADPT Adaptive Biotechnologies Corp
Watch ADPT
Traded
Aug 18, 2026
Disclosed
Aug 20, 2026
Filed
2 days after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Robert Hershberg, Director at Adaptive Biotechnologies, sold ADPT on Aug 18, 2026TRADEDDISCLOSED
ADPTSimilar stocks (XLV — its sector index fund), rebased to ADPT's price on the disclosure day
ADPT since disclosure
−5.6%
after the sale
Similar stocks (XLV) since disclosure
+2.5%
XLV — its sector index fund

Change in closing price from Aug 20, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLRobert Hershberg DirectorADPT Adaptive Biotechnologies Corp$382Kdisclosed Aug 20 · filed 2 days after the trade

See every trade on ADPT →